Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Thomas Ciulla, MD
Clearside Biomedical, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Phoenix, Arizona, United States
- Facility name not stated
Beverly Hills, California, United States
- Facility name not stated
San Diego, California, United States
- Facility name not stated
Boynton Beach, Florida, United States
- Facility name not stated
Atlanta, Georgia, United States
- Facility name not stated
Baltimore, Maryland, United States
- Facility name not stated
St Louis, Missouri, United States
- Facility name not stated
Winston-Salem, North Carolina, United States
- Facility name not stated
Rapid City, South Dakota, United States
- Facility name not stated
Abilene, Texas, United States
- Facility name not stated
Houston, Texas, United States
- Facility name not stated
McAllen, Texas, United States
- Facility name not stated
San Antonio, Texas, United States
- Facility name not stated
The Woodlands, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2015
- Primary completion
- 31 Mar 2016
- Completion
- 31 Mar 2016
- Last update posted
- 8 Feb 2021
- Registered enrollment
- 46
- Registry id
- NCT02303184
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.